4-[p-Chlorobenzyl]-1-methylpiperidine | 508201-25-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 4-[p-Chlorobenzyl]-1-methylpiperidine
• 英文别名: 4-[(4-chlorophenyl)methyl]-1-methylpiperidine
• CAS: 508201-25-0
• 化学式: C₁₃H₁₈ClN
• 分子量: 223.746
• InChiKey: ANAFRPMJEMNXSL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  聚合甲醛 、 4-(4-氯苄基)哌啶 在 甲酸 作用下， 以 二甲基亚砜 为溶剂， 反应 0.02h， 生成 4-[p-Chlorobenzyl]-1-methylpiperidine
  参考文献：
  名称：

  Development of a microwave-enhanced isotopic labelling procedure based on the Eschweiler–Clarke methylation reaction

  摘要：

  A number of primary and secondary amines have been rapidly methylated under microwave-enhanced conditions using formic acid-formaldehyde mixtures, providing a route to H-2(D)-containing compounds and the potential for H-3(T), C-11, C-13 and C-14 labelling. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4039(02)02455-3

文献信息

• [EN] SUBSTITUTED (AZA)INDOLE DERIVATIVES<br/>[FR] DÉRIVÉS D'(AZA)INDOLE SUBSTITUÉS
  申请人：RICHTER GEDEON NYRT

  公开号：WO2020012424A1

  公开（公告）日：2020-01-16

  The invention relates to substituted (aza)indole derivatives, or pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates and hydrates thereof, as well as to pharmaceutical compositions containing them and to their use as modulators of α7 nicotinic acetylcholine receptor activity in a mammalian subject. (I)

  这项发明涉及替代的(氮杂)吲哚衍生物，或其药学上可接受的盐、生物活性代谢物、前药、外消旋体、对映体、二对映异构体、溶剂合物和水合物，以及含有它们的药物组合物，以及它们作为调节哺乳动物主体中α7尼古丁乙酰胆碱受体活性的用途。(I)
• N-sulphonylated amino acid derivatives, method for the production and use thereof
  申请人：Sturzebecher Jorg

  公开号：US20070055065A1

  公开（公告）日：2007-03-08

  The present invention relates to N-sulfonylated amino acid derivatives, where an aryl radical is linked via the sulfonyl group N-terminally to the amino acid and a radical which comprises at least one imino group and at least one further basic group which represents an optionally modified amino, amidino or guanidino group is linked C-terminally via the carbonyl group. The invention likewise relates to processes for preparing these compounds and to their use, in particular as inhibitors of matriptase.

  本发明涉及N-磺酰化氨基酸衍生物，其中芳基基团通过磺酰基N-末端与氨基酸连接，而包含至少一个亚胺基团和至少一个其他碱性基团的基团则通过羰基基团C-末端连接。本发明还涉及制备这些化合物的方法以及它们的用途，特别是作为matriptase的抑制剂。
• 2,3-Dihydro-6-Nitroimidazo (2,1-b) Oxazole Compounds for the Treatment of Tuberculosis
  申请人：Tsubouchi Hidetsugu

  公开号：US20080119478A1

  公开（公告）日：2008-05-22

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: (1) in the above formula (1), R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R1 and —(CH2) n R2 may form a spiro ring represented by the formula (30) below, together with the adjacent carbon atom (in the formula below, RRR represents a piperidyl group which may have substituents on the piperidine ring), (30) and R2 represents a benzothiazolyloxy group, quinolyloxy group, pyridyloxy group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis , multi-drug-resistant Mycobacterium tuberculosis , and atypical acid-fast bacteria.

  本发明提供了一种由下述通式（1）表示的2,3-二氢-6-硝基咪唑[2,1-b]噁唑化合物： 在上述式（1）中，R1代表氢原子或C1-C6烷基，n代表0到6的整数，R1和—(CH2)nR2可以与相邻的碳原子形成如下式（30）所示的螺环，其中，在下式中，RRR代表可能在哌啶环上具有取代基的哌啶基： （30）且R2代表苯并噻唑氧基、喹啉氧基、吡啶氧基或类似基团。该化合物对结核分枝杆菌、多重耐药结核分枝杆菌和非典型酸杆菌具有优异的杀菌作用。
• N-SULPHONYLATED AMINO ACID DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF
  申请人：Stürzebecher Jörg

  公开号：US20110002992A1

  公开（公告）日：2011-01-06

  The present invention relates to N-sulfonylated amino acid derivatives, where an aryl radical is linked via the sulfonyl group N-terminally to the amino acid and a radical which comprises at least one imino group and at least one further basic group which represents an optionally modified amino, amidino or guanidino group is linked C-terminally via the carbonyl group. The invention likewise relates to processes for preparing these compounds and to their use, in particular as inhibitors of matriptase.

  本发明涉及N-磺酰基氨基酸衍生物，其中芳基基团通过磺酰基N末端与氨基酸连接，而包含至少一个亚胺基团和至少一个进一步的碱性基团的基团，该基团表示为可选修饰的氨基，酰胺基或鸟氨酸基团，通过羰基基团C末端连接。本发明还涉及制备这些化合物的方法及其用途，特别是作为matriptase的抑制剂。
• 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS
  申请人：OTSUKA PHARMACEUTICAL CO., LTD.

  公开号：EP1678185B1

  公开（公告）日：2008-10-08